Name
Country
Phase
Design
Date
Polyvalent Anti-scorpion
Fabotherapic vs. Midazolam in Pediatric Patients
USA
Phase 3
FDA
Multi-center,
double-blind random,
controlled with Midazolam
start
Sept-04
end
Oct-05
Polyvalent Latrodectus
Anti-spider Fabotherapic
600/6000
México-Guadalajara
Registration of new
presentation
Single-center
double-blind random
start
Oct-04
end
Dec-05
Polyvalent Anti-scorpion Fabotherapic,
Mexico Pediatric
México
Phase 2
FDA
Series of cases of
multi-center
venenonemia
start
Jan-05
end
Sept-06
Polyvalent Anti-scorpion Fabotherapic,
Mexico Adults
México
Phase 2
FDA
Series of cases of
multi-center
venenonemia
start
Jan-05
end
Sept-06
Polyvalent Anti-snake Fabotherapic, Arizona
FDA
USA
Phase 2
FDA
Open random comparing recurrence of coagulopathy between Crofab and Antivipmyn
start
Jan-05
end
July-06
Latrodectus Polyvalent Anti-spider Fabotherapic, US
FDA
USA
Phase 2
FDA
Multi-center
double-blind random controlled with placebo
start
May-05
end
Sept-06
Polyvalent Anti-snake Fabotherapic for the African Continent
Africa
Phase 3
FDA
Series of multi-center cases
start
April-05
end
June-06
Polyvalent Anti-scorpion Fabotherapic,
Arizona Pediatric
USA
Phase 2
FDA
Series of venenonemia cases
start
Jan-05
end
Sept-06
Polyvalent Anti-snake
Fabotherapic,
Pan African
Africa
Phase 4
Coagulopathy study in patients with viper poisoning
start
June-05
end
June-06
Name
Country
Phase
Design
Date
Polyvalent Anti-scorpion Fabotherapic,
Rural Arizona
USA
Treatment
Protocol
Series of multi-center cases,
financed by the government of Arizona
start
Mar-05
Name
Country
Phase
Design
Date
Polyvalent Anti-snake
Fabotherapic,
Mexico
México
Phase 4
Optimization of therapeutic scheme
start
sept-06
Polyvalent Latrodectus Anti-spider Fabotherapic, US
FDA
USA
Phase 3
FDA
Pending
start
may-07
Polyvalent Loxoceles
Anti-spider Fabotherapic
México
Phase 2
Pending
start
mar-07
Polyvalent Anti-snake
Fabotherapic
USA
Phase 3
Multi-center
start
jun-07
Polyvalent Anti-elapids
Fabotherapic,
African
Africa
Phase 4
Study for patients with
elapid poisoning
start
jun-07
Name/Proyect
BB IND
Objetiv
Polyvalent Anti-scorpion Fabotherapic
FDA
10,371
Sale of Polyvalent Anti-scorpion
Fabotherapic, USA
Polyvalent Anti-snake
Fabotherapic
FDA
11,275
Sale of Polyvalent Anti-snake
Fabotherapic, USA
Polyvalent Latrodectus
Anti-spider Fabotherapic
FDA
11,593
Sale of Polyvalent Latrodectus
Anti-spider Fabotherapic, USA
Polyvalent Anti-snake
Fabotherapic, Pan African
Sale of Polyvalent Anti-snake
Fabotherapic, Pan Africa /Africa
© Instituto Bioclon S.A. de C.V. 2006
Calzada de Tlalpan # 4687, Col. Toriello Guerra. C.P. 14050, México D.F., Tel 56-65-41-11
